SOLID TUMORS, ADULT

Clinical trials for SOLID TUMORS, ADULT explained in plain language.

Never miss a new study

Get alerted when new SOLID TUMORS, ADULT trials appear

Sign up with your email to follow new studies for SOLID TUMORS, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet finished but already full! 1 Completed 1

New hope for hard-to-treat cancers: experimental combo targets STK11 mutation

Disease control Ongoing

This study tests an experimental drug called TNG260 combined with an immunotherapy (pembrolizumab) in people with advanced solid tumors that have a specific gene change (STK11 mutation). The goal is to find the best dose and see if the combination is safe and can shrink tumors. A…

Matched conditions: SOLID TUMORS, ADULT

Phase: PHASE1, PHASE2 • Sponsor: Tango Therapeutics, Inc. • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

SOLID TUMORS, ADULT

Get alerted when new SOLID TUMORS, ADULT trials appear

New hope for hard-to-treat cancers: experimental combo targets STK11 mutation